サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：経腸栄養剤の世界市場
市場調査レポート
商品コード
1198945

経腸栄養剤の世界市場

Enteral Feeding Formulas
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 246 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
経腸栄養剤の世界市場
出版日: 2023年01月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 246 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の経腸栄養剤の市場規模は、分析期間（2022年～2030年）に3.3％のCAGRで成長する展望で、2022年の60億米ドルから、2030年には78億米ドルに達すると予測されています。

当レポートで分析されているセグメントの1つであるスタンダードフォーミュラは、分析期間中に2.4％の年率で成長し、39億米ドルに達すると予測されています。

当レポートは、世界の経腸栄養剤市場について調査しており、Covid-19の影響、動向や成長要因、地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の展望

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他の欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他のアジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他のラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
目次
Product Code: MCP11809

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Enteral Feeding Formulas Market to Reach $7.8 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Enteral Feeding Formulas estimated at US$6 Billion in the year 2022, is projected to reach a revised size of US$7.8 Billion by 2030, growing at aCAGR of 3.3% over the period 2022-2030. Standard Formula, one of the segments analyzed in the report, is projected to record 2.4% CAGR and reach US$3.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Disease-Specific Formulas segment is readjusted to a revised 4.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $1.6 Billion, While China is Forecast to Grow at 5.7% CAGR

The Enteral Feeding Formulas market in the U.S. is estimated at US$1.6 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 5.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.8% and 4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 1.6% CAGR.

Select Competitors (Total 46 Featured):

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Danone SA
  • Fresenius Kabi AG
  • Global Health Products, Inc.
  • Hormel Foods Corporation
  • Mead Johnson Nutrition Company
  • Meiji Holdings Co., Ltd.
  • Nestec, Inc.
  • Victus, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Enteral Feeding Formulas Market to Witness Steady Gains
    • Rapid Growth in Ageing Population to Drive Market Growth
    • Global Population Statistics and Estimates for the 60+ Age Group (1990, 2015, 2050E, 2100E)
    • Enteral Feeding Formulas - Global Key Competitors Percentage Market Share in 2023 (E)
    • Increase in Healthcare Spending Across the Globe to Bolster Market Growth
    • Health Care and GDP Per Capita Spending in USD: 2017
    • Percentage of Healthcare Spending by Expenditure Type: 2017
    • Growth Rates of Healthcare Spending by Spending Type: 2008-20017
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2023 (E)
    • Growing Incidence of Chronic Diseases to Bolster Enteral Feeding Formulas Market
    • Total Number of People Suffering from Chronic Ailments in the US: 1996-2030
    • Preterm Births: Another Contributing Factor for Market Growth
    • Growth in Homecare Demand to Bolster Market Growth
    • With Higher Need for Personalized Medicines, the Market to Register Substantial Gains
    • Total Availability of Personalized Medicines in the US: 2008-2016
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Enteral Feeding Formulas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Enteral Feeding Formulas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 10: World Enteral Feeding Formulas Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Critical Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Critical Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 13: World 16-Year Perspective for Critical Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 16: World 16-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Standard Formula by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Standard Formula by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 19: World 16-Year Perspective for Standard Formula by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Disease-Specific Formulas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Disease-Specific Formulas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 22: World 16-Year Perspective for Disease-Specific Formulas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Adult by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Adult by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 25: World 16-Year Perspective for Adult by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Pediatric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Pediatric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 28: World 16-Year Perspective for Pediatric by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 31: World 16-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Gastroenterology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Gastroenterology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 34: World 16-Year Perspective for Gastroenterology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 37: World 16-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 40: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Enteral Feeding Formulas Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2023 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2023 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 52: USA 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2023 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 61: Canada 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2023 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 64: Canada 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2023 & 2030
  • JAPAN
    • Enteral Feeding Formulas Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2023 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 70: Japan 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 73: Japan 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2023 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 76: Japan 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2023 & 2030
  • CHINA
    • Enteral Feeding Formulas Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 77: China Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 79: China 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2023 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 82: China 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 85: China 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2023 & 2030
    • TABLE 86: China Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: China Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 88: China 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2023 & 2030
  • EUROPE
    • Enteral Feeding Formulas Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Enteral Feeding Formulas by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 91: Europe 16-Year Perspective for Enteral Feeding Formulas by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 94: Europe 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2023 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 97: Europe 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Europe Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 100: Europe 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2023 & 2030
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: Europe Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 103: Europe 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2023 & 2030
  • FRANCE
    • Enteral Feeding Formulas Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 104: France Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 106: France 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2023 & 2030
    • TABLE 107: France Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 109: France 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 110: France Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: France Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 112: France 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2023 & 2030
    • TABLE 113: France Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 114: France Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 115: France 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2023 & 2030
  • GERMANY
    • Enteral Feeding Formulas Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 116: Germany Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 118: Germany 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2023 & 2030
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 121: Germany 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 122: Germany Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Germany Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 124: Germany 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2023 & 2030
    • TABLE 125: Germany Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Germany Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 127: Germany 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 130: Italy 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2023 & 2030
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 133: Italy 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 134: Italy Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Italy Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 136: Italy 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2023 & 2030
    • TABLE 137: Italy Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Italy Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 139: Italy 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Enteral Feeding Formulas Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 140: UK Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 142: UK 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2023 & 2030
    • TABLE 143: UK Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 145: UK 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 146: UK Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 147: UK Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 148: UK 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2023 & 2030
    • TABLE 149: UK Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 150: UK Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 151: UK 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2023 & 2030
  • SPAIN
    • TABLE 152: Spain Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Spain Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 154: Spain 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2023 & 2030
    • TABLE 155: Spain Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 156: Spain Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 157: Spain 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 158: Spain Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 159: Spain Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 160: Spain 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2023 & 2030
    • TABLE 161: Spain Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 162: Spain Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 163: Spain 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2023 & 2030
  • RUSSIA
    • TABLE 164: Russia Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 165: Russia Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 166: Russia 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2023 & 2030
    • TABLE 167: Russia Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 168: Russia Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 169: Russia 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 170: Russia Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 171: Russia Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 172: Russia 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2023 & 2030
    • TABLE 173: Russia Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 174: Russia Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 175: Russia 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 177: Rest of Europe Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 178: Rest of Europe 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2023 & 2030
    • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 180: Rest of Europe Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 181: Rest of Europe 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 183: Rest of Europe Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 184: Rest of Europe 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2023 & 2030
    • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 186: Rest of Europe Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 187: Rest of Europe 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Enteral Feeding Formulas Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 189: Asia-Pacific Historic Review for Enteral Feeding Formulas by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 190: Asia-Pacific 16-Year Perspective for Enteral Feeding Formulas by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 193: Asia-Pacific 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2023 & 2030
    • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 195: Asia-Pacific Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 196: Asia-Pacific 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 198: Asia-Pacific Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 199: Asia-Pacific 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2023 & 2030
    • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 201: Asia-Pacific Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 202: Asia-Pacific 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2023 & 2030
  • AUSTRALIA
    • Enteral Feeding Formulas Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 203: Australia Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 204: Australia Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 205: Australia 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2023 & 2030
    • TABLE 206: Australia Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 207: Australia Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 208: Australia 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 209: Australia Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 210: Australia Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 211: Australia 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2023 & 2030
    • TABLE 212: Australia Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 213: Australia Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 214: Australia 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2023 & 2030
  • INDIA
    • Enteral Feeding Formulas Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • TABLE 215: India Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 216: India Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 217: India 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2023 & 2030
    • TABLE 218: India Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 219: India Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 220: India 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 221: India Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 222: India Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 223: India 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2023 & 2030
    • TABLE 224: India Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 225: India Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 226: India 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2023 & 2030
  • SOUTH KOREA
    • TABLE 227: South Korea Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 228: South Korea Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 229: South Korea 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2023 & 2030
    • TABLE 230: South Korea Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 231: South Korea Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 232: South Korea 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 233: South Korea Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 234: South Korea Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 235: South Korea 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2023 & 2030
    • TABLE 236: South Korea Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 237: South Korea Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 238: South Korea 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 240: Rest of Asia-Pacific Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 241: Rest of Asia-Pacific 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2023 & 2030
    • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 243: Rest of Asia-Pacific Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 244: Rest of Asia-Pacific 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 246: Rest of Asia-Pacific Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 247: Rest of Asia-Pacific 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2023 & 2030
    • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 249: Rest of Asia-Pacific Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 250: Rest of Asia-Pacific 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2023 & 2030
  • LATIN AMERICA
    • Enteral Feeding Formulas Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 251: Latin America Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 252: Latin America Historic Review for Enteral Feeding Formulas by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 253: Latin America 16-Year Perspective for Enteral Feeding Formulas by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2023 & 2030
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 256: Latin America 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2023 & 2030
    • TABLE 257: Latin America Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 258: Latin America Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 259: Latin America 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 260: Latin America Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 261: Latin America Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 262: Latin America 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2023 & 2030
    • TABLE 263: Latin America Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 264: Latin America Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 265: Latin America 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2023 & 2030
  • ARGENTINA
    • TABLE 266: Argentina Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 267: Argentina Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 268: Argentina 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2023 & 2030
    • TABLE 269: Argentina Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 270: Argentina Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 271: Argentina 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 272: Argentina Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 273: Argentina Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 274: Argentina 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2023 & 2030
    • TABLE 275: Argentina Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 276: Argentina Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 277: Argentina 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2023 & 2030
  • BRAZIL
    • TABLE 278: Brazil Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 279: Brazil Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 280: Brazil 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2023 & 2030
    • TABLE 281: Brazil Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 282: Brazil Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 283: Brazil 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 284: Brazil Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 285: Brazil Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 286: Brazil 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2023 & 2030
    • TABLE 287: Brazil Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 288: Brazil Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 289: Brazil 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2023 & 2030
  • MEXICO
    • TABLE 290: Mexico Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 291: Mexico Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 292: Mexico 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2023 & 2030
    • TABLE 293: Mexico Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 294: Mexico Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 295: Mexico 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 296: Mexico Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 297: Mexico Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 298: Mexico 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2023 & 2030
    • TABLE 299: Mexico Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 300: Mexico Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 301: Mexico 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2023 & 2030
  • REST OF LATIN AMERICA
    • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 303: Rest of Latin America Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 304: Rest of Latin America 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2023 & 2030
    • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 306: Rest of Latin America Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 307: Rest of Latin America 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 309: Rest of Latin America Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 310: Rest of Latin America 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2023 & 2030
    • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 312: Rest of Latin America Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 313: Rest of Latin America 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2023 & 2030
  • MIDDLE EAST
    • Enteral Feeding Formulas Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 314: Middle East Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 315: Middle East Historic Review for Enteral Feeding Formulas by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 316: Middle East 16-Year Perspective for Enteral Feeding Formulas by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2023 & 2030
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 319: Middle East 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2023 & 2030
    • TABLE 320: Middle East Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 321: Middle East Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 322: Middle East 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 323: Middle East Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 324: Middle East Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 325: Middle East 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2023 & 2030
    • TABLE 326: Middle East Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 327: Middle East Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 328: Middle East 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2023 & 2030
  • IRAN
    • TABLE 329: Iran Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 330: Iran Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 331: Iran 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2023 & 2030
    • TABLE 332: Iran Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 333: Iran Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 334: Iran 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 335: Iran Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 336: Iran Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 337: Iran 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2023 & 2030
    • TABLE 338: Iran Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 339: Iran Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 340: Iran 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2023 & 2030
  • ISRAEL
    • TABLE 341: Israel Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 342: Israel Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 343: Israel 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2023 & 2030
    • TABLE 344: Israel Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 345: Israel Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 346: Israel 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 347: Israel Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 348: Israel Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 349: Israel 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2023 & 2030
    • TABLE 350: Israel Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 351: Israel Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 352: Israel 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2023 & 2030
  • SAUDI ARABIA
    • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 354: Saudi Arabia Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 355: Saudi Arabia 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2023 & 2030
    • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 357: Saudi Arabia Historic Review for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 358: Saudi Arabia 16-Year Perspective for Enteral Feeding Formulas by Application - Percentage Breakdown of Value Sales for Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications for the Years 2014, 2023 & 2030
    • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Enteral Feeding Formulas by End-Use - Home Care and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 360: Saudi Arabia Historic Review for Enteral Feeding Formulas by End-Use - Home Care and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 361: Saudi Arabia 16-Year Perspective for Enteral Feeding Formulas by End-Use - Percentage Breakdown of Value Sales for Home Care and Hospitals for the Years 2014, 2023 & 2030
    • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Stage - Adult and Pediatric - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 363: Saudi Arabia Historic Review for Enteral Feeding Formulas by Stage - Adult and Pediatric Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 364: Saudi Arabia 16-Year Perspective for Enteral Feeding Formulas by Stage - Percentage Breakdown of Value Sales for Adult and Pediatric for the Years 2014, 2023 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 365: UAE Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 366: UAE Historic Review for Enteral Feeding Formulas by Product - Standard Formula and Disease-Specific Formulas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 367: UAE 16-Year Perspective for Enteral Feeding Formulas by Product - Percentage Breakdown of Value Sales for Standard Formula and Disease-Specific Formulas for the Years 2014, 2023 & 2030
    • TABLE 368: UAE Recent Past, Current & Future Analysis for Enteral Feeding Formulas by Application - Oncology, Gastroenterology, Critical Care, Neurology, Diabetes and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Year